Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 883.37M | $ 614.38M | $ 486.82M | $ 316.38M | $ 216.14M |
| Gross Profit | $ 450.64M | $ 364.17M | $ 305.30M | $ 177.60M | $ 115.53M |
| Operating Income | $ 81.23M | $ 584.00K | $ 46.97M | $ -35.28M | $ -39.79M |
| EBITDA | $ 207.27M | $ 63.12M | $ 106.60M | $ 25.04M | $ 3.12M |
| Net Income | $ 78.34M | $ -18.52M | $ 18.78M | $ -47.90M | $ -42.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 285.58M | $ 151.17M | $ 221.12M | $ 48.23M | $ 100.30M |
| Total Assets | $ 1.44B | $ 1.28B | $ 904.42M | $ 760.09M | $ 771.60M |
| Total Debt | $ 325.19M | $ 624.09M | $ 285.67M | $ 286.52M | $ 287.37M |
| Net Debt | $ 39.61M | $ 479.23M | $ 64.55M | $ 238.29M | $ 187.07M |
| Total Liabilities | $ 899.65M | $ 855.17M | $ 446.82M | $ 421.55M | $ 412.86M |
| Stockholders' Equity | $ 540.72M | $ 428.53M | $ 457.60M | $ 338.54M | $ 358.74M |
| Cash Flow | |||||
| Free Cash Flow | $ 171.39M | $ 47.06M | $ 100.45M | $ -47.66M | $ -20.32M |
| Operating Cash Flow | $ 185.22M | $ 64.02M | $ 118.96M | $ -31.20M | $ 3.32M |
| Investing Cash Flow | $ -34.32M | $ -404.72M | $ -18.51M | $ -15.74M | $ -105.48M |
| Financing Cash Flow | $ -9.94M | $ 264.94M | $ 67.44M | $ -5.13M | $ 194.59M |